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SUMMARY. Studies to evaluate the clinical efficacy and safety of various topical NSAIDS compared to
oral NSAIDS have been reported but little research has been conducted to evaluate the efficacy of topical
NSAIDS from different manufacturers containing the same concentation of medicament. The aim of this
study was to make comparison of the in vitro release rate of three proprietary Diclofenac gels. To study the
in vitro potential of these formulation permeation studies were performed with Franz diffusion cell by us-
ing cellulose acetate membrane. In vitro permeation study was found that the diffusion profile of A gel was
equivalent to Voveran Emulgel while B gel was significantly (p < 0.05) lower than Voveran Emulgel. This
data indicates that the simple denotation of Diclofenac sodium 1% w/w gel is inadequate as a means of dis-
tinguishing between similar formulations of different manufacturers that might contain the same types of
excipients. This highlights the potential problems that may arise from the mistaken assumption that
generic prescriptions and formulations are pharmaceutically and clinically equivalent and interchange-
able.
